nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—Warmth—Liotrix—hypothyroidism	0.025	0.0277	CcSEcCtD
Dexmethylphenidate—Serum sickness—Dextrothyroxine—hypothyroidism	0.0231	0.0256	CcSEcCtD
Dexmethylphenidate—Serum sickness—Levothyroxine—hypothyroidism	0.0231	0.0256	CcSEcCtD
Dexmethylphenidate—Muscle twitching—Liothyronine—hypothyroidism	0.0224	0.0248	CcSEcCtD
Dexmethylphenidate—Serum sickness—Liotrix—hypothyroidism	0.017	0.0188	CcSEcCtD
Dexmethylphenidate—Angina pectoris—Liothyronine—hypothyroidism	0.0135	0.0149	CcSEcCtD
Dexmethylphenidate—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0122	0.0135	CcSEcCtD
Dexmethylphenidate—Myocardial infarction—Liothyronine—hypothyroidism	0.0121	0.0134	CcSEcCtD
Dexmethylphenidate—Feeling hot—Liotrix—hypothyroidism	0.0101	0.0112	CcSEcCtD
Dexmethylphenidate—Abscess—Liotrix—hypothyroidism	0.0101	0.0111	CcSEcCtD
Dexmethylphenidate—Coma—Levothyroxine—hypothyroidism	0.00989	0.0109	CcSEcCtD
Dexmethylphenidate—Coma—Dextrothyroxine—hypothyroidism	0.00989	0.0109	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Liothyronine—hypothyroidism	0.00989	0.0109	CcSEcCtD
Dexmethylphenidate—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00944	0.0105	CcSEcCtD
Dexmethylphenidate—Hyperkinesia—Levothyroxine—hypothyroidism	0.00944	0.0105	CcSEcCtD
Dexmethylphenidate—SLC6A4—Monoamine Transport—SLC5A7—hypothyroidism	0.00934	0.107	CbGpPWpGaD
Dexmethylphenidate—Disorientation—Dextrothyroxine—hypothyroidism	0.00878	0.00972	CcSEcCtD
Dexmethylphenidate—Disorientation—Levothyroxine—hypothyroidism	0.00878	0.00972	CcSEcCtD
Dexmethylphenidate—SLC6A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00846	0.0969	CbGpPWpGaD
Dexmethylphenidate—Ulcer—Liotrix—hypothyroidism	0.00842	0.00932	CcSEcCtD
Dexmethylphenidate—Increased appetite—Dextrothyroxine—hypothyroidism	0.00836	0.00926	CcSEcCtD
Dexmethylphenidate—Increased appetite—Levothyroxine—hypothyroidism	0.00836	0.00926	CcSEcCtD
Dexmethylphenidate—Hypertension—Liothyronine—hypothyroidism	0.00832	0.00921	CcSEcCtD
Dexmethylphenidate—Muscle twitching—Liotrix—hypothyroidism	0.00811	0.00898	CcSEcCtD
Dexmethylphenidate—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00805	0.00891	CcSEcCtD
Dexmethylphenidate—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00805	0.00891	CcSEcCtD
Dexmethylphenidate—SLC6A2—Monoamine Transport—SLC5A7—hypothyroidism	0.00803	0.092	CbGpPWpGaD
Dexmethylphenidate—Affect lability—Dextrothyroxine—hypothyroidism	0.00774	0.00856	CcSEcCtD
Dexmethylphenidate—Affect lability—Levothyroxine—hypothyroidism	0.00774	0.00856	CcSEcCtD
Dexmethylphenidate—Tachycardia—Liothyronine—hypothyroidism	0.00768	0.0085	CcSEcCtD
Dexmethylphenidate—Irritability—Levothyroxine—hypothyroidism	0.0075	0.0083	CcSEcCtD
Dexmethylphenidate—Irritability—Dextrothyroxine—hypothyroidism	0.0075	0.0083	CcSEcCtD
Dexmethylphenidate—SLC6A3—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.0075	0.0858	CbGpPWpGaD
Dexmethylphenidate—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00747	0.00827	CcSEcCtD
Dexmethylphenidate—Cardiac arrest—Levothyroxine—hypothyroidism	0.00747	0.00827	CcSEcCtD
Dexmethylphenidate—Mood swings—Dextrothyroxine—hypothyroidism	0.00744	0.00824	CcSEcCtD
Dexmethylphenidate—Mood swings—Levothyroxine—hypothyroidism	0.00744	0.00824	CcSEcCtD
Dexmethylphenidate—Dehydration—Dextrothyroxine—hypothyroidism	0.00731	0.00809	CcSEcCtD
Dexmethylphenidate—Dehydration—Levothyroxine—hypothyroidism	0.00731	0.00809	CcSEcCtD
Dexmethylphenidate—Coma—Liotrix—hypothyroidism	0.00728	0.00805	CcSEcCtD
Dexmethylphenidate—SLC6A3—Monoamine Transport—SLC5A7—hypothyroidism	0.00712	0.0815	CbGpPWpGaD
Dexmethylphenidate—Hyperkinesia—Liotrix—hypothyroidism	0.00695	0.00769	CcSEcCtD
Dexmethylphenidate—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00662	0.00732	CcSEcCtD
Dexmethylphenidate—Angina pectoris—Levothyroxine—hypothyroidism	0.00662	0.00732	CcSEcCtD
Dexmethylphenidate—Swelling—Liotrix—hypothyroidism	0.00655	0.00725	CcSEcCtD
Dexmethylphenidate—Disorientation—Liotrix—hypothyroidism	0.00646	0.00715	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Liothyronine—hypothyroidism	0.00622	0.00688	CcSEcCtD
Dexmethylphenidate—Increased appetite—Liotrix—hypothyroidism	0.00615	0.00681	CcSEcCtD
Dexmethylphenidate—Weight decreased—Levothyroxine—hypothyroidism	0.00614	0.0068	CcSEcCtD
Dexmethylphenidate—Weight decreased—Dextrothyroxine—hypothyroidism	0.00614	0.0068	CcSEcCtD
Dexmethylphenidate—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00597	0.00661	CcSEcCtD
Dexmethylphenidate—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00597	0.00661	CcSEcCtD
Dexmethylphenidate—Myocardial infarction—Levothyroxine—hypothyroidism	0.00594	0.00657	CcSEcCtD
Dexmethylphenidate—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00594	0.00657	CcSEcCtD
Dexmethylphenidate—Hypoglycaemia—Liotrix—hypothyroidism	0.00592	0.00656	CcSEcCtD
Dexmethylphenidate—Cerebrovascular accident—Liotrix—hypothyroidism	0.0059	0.00653	CcSEcCtD
Dexmethylphenidate—Sweating—Dextrothyroxine—hypothyroidism	0.00581	0.00643	CcSEcCtD
Dexmethylphenidate—Sweating—Levothyroxine—hypothyroidism	0.00581	0.00643	CcSEcCtD
Dexmethylphenidate—Affect lability—Liotrix—hypothyroidism	0.00569	0.0063	CcSEcCtD
Dexmethylphenidate—Irritability—Liotrix—hypothyroidism	0.00552	0.00611	CcSEcCtD
Dexmethylphenidate—Cardiac arrest—Liotrix—hypothyroidism	0.0055	0.00608	CcSEcCtD
Dexmethylphenidate—Mood swings—Liotrix—hypothyroidism	0.00548	0.00606	CcSEcCtD
Dexmethylphenidate—Dehydration—Liotrix—hypothyroidism	0.00538	0.00595	CcSEcCtD
Dexmethylphenidate—Flushing—Levothyroxine—hypothyroidism	0.00505	0.00558	CcSEcCtD
Dexmethylphenidate—Flushing—Dextrothyroxine—hypothyroidism	0.00505	0.00558	CcSEcCtD
Dexmethylphenidate—Angina pectoris—Liotrix—hypothyroidism	0.00487	0.00539	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Levothyroxine—hypothyroidism	0.00486	0.00538	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00486	0.00538	CcSEcCtD
Dexmethylphenidate—Bronchitis—Liotrix—hypothyroidism	0.0048	0.00532	CcSEcCtD
Dexmethylphenidate—Alopecia—Dextrothyroxine—hypothyroidism	0.0048	0.00532	CcSEcCtD
Dexmethylphenidate—Alopecia—Levothyroxine—hypothyroidism	0.0048	0.00532	CcSEcCtD
Dexmethylphenidate—Tension—Levothyroxine—hypothyroidism	0.00464	0.00514	CcSEcCtD
Dexmethylphenidate—Tension—Dextrothyroxine—hypothyroidism	0.00464	0.00514	CcSEcCtD
Dexmethylphenidate—Nervousness—Levothyroxine—hypothyroidism	0.0046	0.00509	CcSEcCtD
Dexmethylphenidate—Nervousness—Dextrothyroxine—hypothyroidism	0.0046	0.00509	CcSEcCtD
Dexmethylphenidate—Weight decreased—Liotrix—hypothyroidism	0.00452	0.005	CcSEcCtD
Dexmethylphenidate—SLC6A4—Synaptic Vesicle Pathway—CLTC—hypothyroidism	0.00446	0.0511	CbGpPWpGaD
Dexmethylphenidate—Tremor—Levothyroxine—hypothyroidism	0.00443	0.00491	CcSEcCtD
Dexmethylphenidate—Tremor—Dextrothyroxine—hypothyroidism	0.00443	0.00491	CcSEcCtD
Dexmethylphenidate—Acute coronary syndrome—Liotrix—hypothyroidism	0.00439	0.00486	CcSEcCtD
Dexmethylphenidate—Myocardial infarction—Liotrix—hypothyroidism	0.00437	0.00483	CcSEcCtD
Dexmethylphenidate—Agitation—Dextrothyroxine—hypothyroidism	0.00435	0.00481	CcSEcCtD
Dexmethylphenidate—Agitation—Levothyroxine—hypothyroidism	0.00435	0.00481	CcSEcCtD
Dexmethylphenidate—Angioedema—Dextrothyroxine—hypothyroidism	0.00432	0.00479	CcSEcCtD
Dexmethylphenidate—Angioedema—Levothyroxine—hypothyroidism	0.00432	0.00479	CcSEcCtD
Dexmethylphenidate—Sweating—Liotrix—hypothyroidism	0.00427	0.00473	CcSEcCtD
Dexmethylphenidate—Palpitations—Dextrothyroxine—hypothyroidism	0.00418	0.00463	CcSEcCtD
Dexmethylphenidate—Palpitations—Levothyroxine—hypothyroidism	0.00418	0.00463	CcSEcCtD
Dexmethylphenidate—Convulsion—Dextrothyroxine—hypothyroidism	0.0041	0.00454	CcSEcCtD
Dexmethylphenidate—Convulsion—Levothyroxine—hypothyroidism	0.0041	0.00454	CcSEcCtD
Dexmethylphenidate—Arthralgia—Dextrothyroxine—hypothyroidism	0.00403	0.00446	CcSEcCtD
Dexmethylphenidate—Arthralgia—Levothyroxine—hypothyroidism	0.00403	0.00446	CcSEcCtD
Dexmethylphenidate—Anxiety—Levothyroxine—hypothyroidism	0.00402	0.00444	CcSEcCtD
Dexmethylphenidate—Anxiety—Dextrothyroxine—hypothyroidism	0.00402	0.00444	CcSEcCtD
Dexmethylphenidate—Confusional state—Dextrothyroxine—hypothyroidism	0.00389	0.00431	CcSEcCtD
Dexmethylphenidate—Confusional state—Levothyroxine—hypothyroidism	0.00389	0.00431	CcSEcCtD
Dexmethylphenidate—Shock—Dextrothyroxine—hypothyroidism	0.0038	0.00421	CcSEcCtD
Dexmethylphenidate—Shock—Levothyroxine—hypothyroidism	0.0038	0.00421	CcSEcCtD
Dexmethylphenidate—Tachycardia—Dextrothyroxine—hypothyroidism	0.00377	0.00417	CcSEcCtD
Dexmethylphenidate—Tachycardia—Levothyroxine—hypothyroidism	0.00377	0.00417	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00373	0.00413	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00373	0.00413	CcSEcCtD
Dexmethylphenidate—Flushing—Liotrix—hypothyroidism	0.00371	0.00411	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Liotrix—hypothyroidism	0.00357	0.00395	CcSEcCtD
Dexmethylphenidate—Alopecia—Liotrix—hypothyroidism	0.00353	0.00391	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00352	0.0039	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00352	0.0039	CcSEcCtD
Dexmethylphenidate—Insomnia—Levothyroxine—hypothyroidism	0.00349	0.00387	CcSEcCtD
Dexmethylphenidate—Insomnia—Dextrothyroxine—hypothyroidism	0.00349	0.00387	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00344	0.00381	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Levothyroxine—hypothyroidism	0.00344	0.00381	CcSEcCtD
Dexmethylphenidate—Tension—Liotrix—hypothyroidism	0.00342	0.00378	CcSEcCtD
Dexmethylphenidate—Nervousness—Liotrix—hypothyroidism	0.00338	0.00374	CcSEcCtD
Dexmethylphenidate—Fatigue—Dextrothyroxine—hypothyroidism	0.00333	0.00369	CcSEcCtD
Dexmethylphenidate—Fatigue—Levothyroxine—hypothyroidism	0.00333	0.00369	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00331	0.0379	CbGpPWpGaD
Dexmethylphenidate—Vision blurred—Liotrix—hypothyroidism	0.00328	0.00363	CcSEcCtD
Dexmethylphenidate—Tremor—Liotrix—hypothyroidism	0.00326	0.00361	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00323	0.037	CbGpPWpGaD
Dexmethylphenidate—Agitation—Liotrix—hypothyroidism	0.0032	0.00354	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00318	0.00352	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Levothyroxine—hypothyroidism	0.00318	0.00352	CcSEcCtD
Dexmethylphenidate—Angioedema—Liotrix—hypothyroidism	0.00318	0.00352	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00316	0.0035	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00316	0.0035	CcSEcCtD
Dexmethylphenidate—Syncope—Liotrix—hypothyroidism	0.00312	0.00346	CcSEcCtD
Dexmethylphenidate—Palpitations—Liotrix—hypothyroidism	0.00308	0.00341	CcSEcCtD
Dexmethylphenidate—Urticaria—Dextrothyroxine—hypothyroidism	0.00307	0.0034	CcSEcCtD
Dexmethylphenidate—Urticaria—Levothyroxine—hypothyroidism	0.00307	0.0034	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Liotrix—hypothyroidism	0.00306	0.00339	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00305	0.00338	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Levothyroxine—hypothyroidism	0.00305	0.00338	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00305	0.00338	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Levothyroxine—hypothyroidism	0.00305	0.00338	CcSEcCtD
Dexmethylphenidate—Convulsion—Liotrix—hypothyroidism	0.00302	0.00334	CcSEcCtD
Dexmethylphenidate—Hypertension—Liotrix—hypothyroidism	0.00301	0.00333	CcSEcCtD
Dexmethylphenidate—Arthralgia—Liotrix—hypothyroidism	0.00296	0.00328	CcSEcCtD
Dexmethylphenidate—Chest pain—Liotrix—hypothyroidism	0.00296	0.00328	CcSEcCtD
Dexmethylphenidate—Anxiety—Liotrix—hypothyroidism	0.00295	0.00327	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00293	0.0336	CbGpPWpGaD
Dexmethylphenidate—Confusional state—Liotrix—hypothyroidism	0.00286	0.00317	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Liotrix—hypothyroidism	0.00284	0.00314	CcSEcCtD
Dexmethylphenidate—Oedema—Liotrix—hypothyroidism	0.00284	0.00314	CcSEcCtD
Dexmethylphenidate—Infection—Liotrix—hypothyroidism	0.00282	0.00312	CcSEcCtD
Dexmethylphenidate—Shock—Liotrix—hypothyroidism	0.0028	0.00309	CcSEcCtD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC5A7—hypothyroidism	0.00277	0.0318	CbGpPWpGaD
Dexmethylphenidate—Tachycardia—Liotrix—hypothyroidism	0.00277	0.00307	CcSEcCtD
Dexmethylphenidate—Asthenia—Levothyroxine—hypothyroidism	0.00277	0.00307	CcSEcCtD
Dexmethylphenidate—Asthenia—Dextrothyroxine—hypothyroidism	0.00277	0.00307	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Liotrix—hypothyroidism	0.00275	0.00304	CcSEcCtD
Dexmethylphenidate—Pruritus—Dextrothyroxine—hypothyroidism	0.00273	0.00302	CcSEcCtD
Dexmethylphenidate—Pruritus—Levothyroxine—hypothyroidism	0.00273	0.00302	CcSEcCtD
Dexmethylphenidate—Anorexia—Liotrix—hypothyroidism	0.00271	0.003	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00264	0.00293	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Levothyroxine—hypothyroidism	0.00264	0.00293	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00259	0.00287	CcSEcCtD
Dexmethylphenidate—Insomnia—Liotrix—hypothyroidism	0.00257	0.00284	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Liotrix—hypothyroidism	0.00255	0.00282	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Liotrix—hypothyroidism	0.00253	0.0028	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Liotrix—hypothyroidism	0.00247	0.00273	CcSEcCtD
Dexmethylphenidate—Vomiting—Dextrothyroxine—hypothyroidism	0.00246	0.00272	CcSEcCtD
Dexmethylphenidate—Vomiting—Levothyroxine—hypothyroidism	0.00246	0.00272	CcSEcCtD
Dexmethylphenidate—Fatigue—Liotrix—hypothyroidism	0.00245	0.00271	CcSEcCtD
Dexmethylphenidate—Rash—Dextrothyroxine—hypothyroidism	0.00244	0.0027	CcSEcCtD
Dexmethylphenidate—Rash—Levothyroxine—hypothyroidism	0.00244	0.0027	CcSEcCtD
Dexmethylphenidate—Dermatitis—Levothyroxine—hypothyroidism	0.00243	0.00269	CcSEcCtD
Dexmethylphenidate—Dermatitis—Dextrothyroxine—hypothyroidism	0.00243	0.00269	CcSEcCtD
Dexmethylphenidate—Constipation—Liotrix—hypothyroidism	0.00243	0.00269	CcSEcCtD
Dexmethylphenidate—Headache—Levothyroxine—hypothyroidism	0.00242	0.00268	CcSEcCtD
Dexmethylphenidate—Headache—Dextrothyroxine—hypothyroidism	0.00242	0.00268	CcSEcCtD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC5A7—hypothyroidism	0.00239	0.0273	CbGpPWpGaD
Dexmethylphenidate—Feeling abnormal—Liotrix—hypothyroidism	0.00234	0.00259	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Liotrix—hypothyroidism	0.00232	0.00257	CcSEcCtD
Dexmethylphenidate—Nausea—Levothyroxine—hypothyroidism	0.00229	0.00254	CcSEcCtD
Dexmethylphenidate—Nausea—Dextrothyroxine—hypothyroidism	0.00229	0.00254	CcSEcCtD
Dexmethylphenidate—Urticaria—Liotrix—hypothyroidism	0.00226	0.0025	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Liotrix—hypothyroidism	0.00225	0.00249	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Liotrix—hypothyroidism	0.00225	0.00249	CcSEcCtD
Dexmethylphenidate—SLC6A3—nerve—hypothyroidism	0.00213	0.231	CbGeAlD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC5A7—hypothyroidism	0.00211	0.0242	CbGpPWpGaD
Dexmethylphenidate—Hypersensitivity—Liotrix—hypothyroidism	0.00209	0.00232	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00208	0.0238	CbGpPWpGaD
Dexmethylphenidate—Asthenia—Liotrix—hypothyroidism	0.00204	0.00226	CcSEcCtD
Dexmethylphenidate—Pruritus—Liotrix—hypothyroidism	0.00201	0.00222	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Liotrix—hypothyroidism	0.00194	0.00215	CcSEcCtD
Dexmethylphenidate—Dizziness—Liotrix—hypothyroidism	0.00188	0.00208	CcSEcCtD
Dexmethylphenidate—Vomiting—Liotrix—hypothyroidism	0.00181	0.002	CcSEcCtD
Dexmethylphenidate—Rash—Liotrix—hypothyroidism	0.00179	0.00198	CcSEcCtD
Dexmethylphenidate—Dermatitis—Liotrix—hypothyroidism	0.00179	0.00198	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00178	0.0204	CbGpPWpGaD
Dexmethylphenidate—Headache—Liotrix—hypothyroidism	0.00178	0.00197	CcSEcCtD
Dexmethylphenidate—SLC6A2—nerve—hypothyroidism	0.00172	0.186	CbGeAlD
Dexmethylphenidate—Nausea—Liotrix—hypothyroidism	0.00169	0.00187	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00164	0.0188	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.0015	0.0172	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—urine—hypothyroidism	0.00136	0.148	CbGeAlD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00133	0.0153	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—SLC5A7—hypothyroidism	0.00126	0.0144	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00125	0.0143	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC5A5—hypothyroidism	0.00111	0.0127	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.0011	0.0126	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00106	0.0121	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC5A5—hypothyroidism	0.000954	0.0109	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC5A5—hypothyroidism	0.000845	0.00967	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000828	0.00948	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—NEFL—hypothyroidism	0.000811	0.00929	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000764	0.00875	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000677	0.00775	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—AVP—hypothyroidism	0.000676	0.00774	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000633	0.00725	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000601	0.00688	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000561	0.00642	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—gonad—hypothyroidism	0.000546	0.0592	CbGeAlD
Dexmethylphenidate—SLC6A4—blood—hypothyroidism	0.000541	0.0586	CbGeAlD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000532	0.0061	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—testis—hypothyroidism	0.000488	0.0529	CbGeAlD
Dexmethylphenidate—SLC6A2—adrenal gland—hypothyroidism	0.000476	0.0516	CbGeAlD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000473	0.00542	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—cerebellum—hypothyroidism	0.000451	0.0488	CbGeAlD
Dexmethylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000422	0.00483	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000419	0.0048	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—testis—hypothyroidism	0.000394	0.0427	CbGeAlD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000342	0.00391	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000305	0.0035	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000271	0.0031	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—blood—hypothyroidism	0.000261	0.0282	CbGeAlD
Dexmethylphenidate—CYP2D6—female gonad—hypothyroidism	0.000243	0.0263	CbGeAlD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00024	0.00275	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—testis—hypothyroidism	0.000216	0.0234	CbGeAlD
Dexmethylphenidate—CYP2D6—Metabolism—IYD—hypothyroidism	0.000214	0.00245	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000213	0.00244	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—liver—hypothyroidism	0.000204	0.0221	CbGeAlD
Dexmethylphenidate—CYP2D6—cerebellum—hypothyroidism	0.000199	0.0216	CbGeAlD
Dexmethylphenidate—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000182	0.00209	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000182	0.00208	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—TPO—hypothyroidism	0.000171	0.00196	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—TSHB—hypothyroidism	7.93e-05	0.000908	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	7.07e-05	0.000809	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SLC5A5—hypothyroidism	5.94e-05	0.00068	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—POMC—hypothyroidism	3.11e-05	0.000356	CbGpPWpGaD
